Predicting subacute hematological toxicity of 177Lu-DOTATATE therapy using healthy organs’ uptake on post-treatment quantitative SPECT: A pilot study

The aim is to investigate the usefulness of (177)Lu-DOTA-0-Tyr3-Octreotate (DOTATATE) healthy organs’ (spleen, kidneys, bone marrow) standard uptake value for the prediction of subacute hematological toxicity in patients undergoing (177)Lu-DOTATATE treatment. All patients referred from January 2021...

Descripción completa

Detalles Bibliográficos
Autores principales: Morland, David, Triumbari, Elizabeth Katherine Anna, Hoog, Christopher, Sézin, Ghali, Dejust, Sébastien, Cadiot, Guillaume, Paris, Pierre, Papathanassiou, Dimitri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9750522/
https://www.ncbi.nlm.nih.gov/pubmed/36626520
http://dx.doi.org/10.1097/MD.0000000000032212

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9750522/
https://www.ncbi.nlm.nih.gov/pubmed/36626520
http://dx.doi.org/10.1097/MD.0000000000032212

Ejemplares similares